We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, DOJ File Complaint Against Arkansas Compounder Following GMP Deviations
FDA, DOJ File Complaint Against Arkansas Compounder Following GMP Deviations
Following FDA inspections and a warning letter, the Department of Justice filed a civil complaint against the outsourcing facility Cantrell Drug Company, of Little Rock, Arkansas seeking a preliminary injunction to halt manufacturing and order the company to recall and destroy all drugs compounded, held or distributed.